The Role of Nutrition in the Development of Alzheimer’s disease - an evaluation of current research
Date: 29 September 2020
Time: 4:00pm to 5:00pm
About the event:
(This event is for health professionals)
The prevalence and socio-economic burdens of dementia are soaring in step with increased number of elderly. Although at the moment there is no treatment for dementia, recent estimates suggest that over half of dementia burden might be attributed to potentially modifiable risk factors. As such, nutrition has been considered as an important risk factor for cognitive decline and dementia. Numerous studies have investigated different aspects of this association. In this talk, we evaluate current evidence for the role of nutrition in the development of dementia, cognitive decline, and structural brain changes in longitudinal studies. Furthermore, evidence from randomized controlled trials will be briefly reviewed. We will then briefly review studies considering vitamin B12, as an example of an important nutrient, and discuss important issues to be considered when investigating its association with cognitive decline.
Dr. Babak Hooshmand is currently completing his final year in clinical specialization in neurology in Ulm University Hospital, Ulm, Germany. Babak is a medical doctor, has a MPH in public health nutrition from Karolinska Institute, and obtained his PhD at the Aging Research, Karolinska Institute. His major research interests include the impact of modifiable risk factors, especially nutritional and vascular risk factors, on dementia, stroke, cognitive performance, and structural brain changes in population-based as well as clinical-based studies.